Yajie Lu Selected Research

Yajie Lu Research Topics

Disease

12	Neoplasms (Cancer) 01/2024 - 07/2008
11	Hearing Loss (Hearing Impairment) 01/2022 - 12/2008
7	Deafness (Deaf Mutism) 01/2020 - 12/2008
6	Sarcoma (Soft Tissue Sarcoma) 01/2024 - 01/2021
5	Osteosarcoma (Osteogenic Sarcoma) 06/2023 - 06/2019
3	Neoplasm Metastasis (Metastasis) 06/2023 - 06/2019
3	Nonsyndromic Deafness 01/2019 - 07/2013
3	Breast Neoplasms (Breast Cancer) 03/2013 - 07/2008
2	Necrosis 10/2023 - 03/2023
2	Infections 03/2023 - 01/2022
2	Nonsyndromic sensorineural hearing loss 07/2013 - 09/2011
2	Carcinogenesis 03/2013 - 09/2009
1	Invasive Pulmonary Aspergillosis 06/2023
1	Pulmonary Aspergillosis 06/2023
1	Heart Diseases (Heart Disease) 03/2023
1	Wounds and Injuries (Trauma) 01/2023
1	Squamous Cell Carcinoma of Head and Neck 01/2023
1	Pancreatitis 11/2022
1	Myocardial Infarction 10/2022
1	Pain (Aches) 04/2022
1	Aspergillosis 03/2022
1	Mycoses (Diseases, Fungus) 03/2022
1	Fungal Lung Diseases 01/2022
1	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 01/2022
1	Chemical and Drug Induced Liver Injury 01/2022
1	Disease Progression 06/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2021
1	Obesity 05/2021
1	Fatigue 01/2021
1	Hand-Foot Syndrome 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Inflammation (Inflammations) 01/2020
1	Osteonecrosis (Kienbock's Disease) 10/2019

Drug/Important Bio-Agent (IBA)

4	DNA (Deoxyribonucleic Acid)IBA 12/2018 - 10/2008
4	12S ribosomal RNAIBA 07/2013 - 12/2008
3	oxysterol binding proteinIBA 01/2020 - 01/2019
3	Mitochondrial DNA (mtDNA)IBA 07/2013 - 12/2008
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2023
2	Ifosfamide FDA LinkGeneric 02/2023 - 01/2023
2	anlotinibIBA 01/2023 - 06/2021
2	HydrogelsIBA 01/2023 - 10/2022
2	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2020
2	apatinibIBA 06/2021 - 01/2021
2	MicroRNAs (MicroRNA)IBA 11/2014 - 03/2013
2	Ser Transfer RNAIBA 09/2011 - 12/2008
1	ElementsIBA 10/2023
1	Immunoglobulin G (IgG)IBA 06/2023
1	AnthracyclinesIBA 03/2023
1	Etoposide (VP 16)FDA LinkGeneric 02/2023
1	Methotrexate (Mexate)FDA LinkGeneric 02/2023
1	Epirubicin (Ellence)FDA LinkGeneric 02/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023
1	Fibroins (Fibroin)IBA 01/2023
1	CyanoacrylatesIBA 01/2023
1	PolyaminesIBA 01/2023
1	Indomethacin (Indometacin)FDA LinkGeneric 11/2022
1	Diclofenac (SR 38)FDA LinkGeneric 11/2022
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2022
1	NLR ProteinsIBA 03/2022
1	Pattern Recognition ReceptorsIBA 03/2022
1	Voriconazole (Vfend)FDA LinkGeneric 01/2022
1	6-methyladenineIBA 01/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	CholesterolIBA 01/2022
1	IronIBA 01/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2021
1	Tyrosine Kinase InhibitorsIBA 06/2021
1	HeliumIBA 06/2021
1	ArgonIBA 06/2021
1	CateninsIBA 05/2021
1	CytokinesIBA 01/2020
1	artemisinin-naphthoquine combinationIBA 10/2019
1	tricalcium phosphateIBA 10/2019
1	SolutionsIBA 09/2019
1	beta-tricalcium phosphateIBA 06/2019
1	claudin 14IBA 02/2018
1	Tight Junction ProteinsIBA 02/2018
1	Amino Acids FDA Link 06/2015
1	Codon (Codons)IBA 06/2015
1	Prolactin Receptors (Prolactin Receptor)IBA 03/2013
1	ProlactinIBA 03/2013
1	RNA (Ribonucleic Acid)IBA 03/2013
1	AminoglycosidesIBA 02/2013
1	5' Untranslated Regions (5' UTR)IBA 05/2012
1	Histone Deacetylase 1IBA 09/2009

Therapy/Procedure

5	Limb Salvage 06/2023 - 09/2019
4	Therapeutics 01/2024 - 06/2019
2	Immunotherapy 01/2024 - 01/2022
2	Neoadjuvant Therapy 06/2023 - 06/2019
2	Prostheses and Implants (Prosthesis) 03/2023 - 06/2019
2	Drug Therapy (Chemotherapy) 02/2023 - 06/2021
2	Cryosurgery 08/2021 - 06/2021
1	Replacement Arthroplasty 06/2023
1	Osteotomy 06/2023
1	Rectal Administration 11/2022
1	Adjuvant Chemotherapy 04/2022
1	Fracture Fixation 01/2022
1	Arthroplasty 08/2021
1	Operative Surgical Procedures 11/2019
1	Knee Prosthesis 09/2019